Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.

Visa andra versioner (1)

BACKGROUND: Patients with ischaemic stroke or transient ischaemic attack (TIA) are at high risk of recurrent stroke or other cardiovascular events. We compared the selective thromboxane-prostaglandin receptor antagonist terutroban with aspirin in the prevention of cerebral and cardiovascular ischae...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Bousser, MG, Amarenco, P, Chamorro, A, Fisher, M, Ford, I, Fox, K, Hennerici, MG, Mattle, H, Rothwell, P, de Cordoüe, A, Fratacci, MD
Materialtyp:	Journal article
Språk:	English
Publicerad:	2011

Liknande verk

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): A randomised, double-blind, parallel-group trial
av: Bousser, M, et al.
Publicerad: (2011)

Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
av: Bousser, MG, et al.
Publicerad: (2009)

The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.
av: Bousser, MG, et al.
Publicerad: (2009)

Heart rate is a prognostic risk factor for myocardial infarction: a post hoc analysis in the PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack) study population.
av: Fox, K, et al.
Publicerad: (2013)

Heart rate is a prognostic risk factor for myocardial infarction: A post hoc analysis in the PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history of ischemic strOke or tRansient ischeMic attack) study population
av: Fox, K, et al.
Publicerad: (2013)

Rationale, design and patients' baseline characteristics of the PERFORM study
av: Bousser, MG, et al.
Publicerad: (2009)

The Intracranial-B2LEED3S score and the risk of intracranial hemorrhage in ischemic stroke patients under antiplatelet treatment.
av: Amarenco, P, et al.
Publicerad: (2017)

Aspirin and transient ischaemic attacks.
av: Peto, R, et al.
Publicerad: (1979)

Immediate aspirin for suspected ischaemic stroke.
av: Baigent, C, et al.
Publicerad: (1999)

Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke.
av: Rothwell, P, et al.
Publicerad: (2011)

Medical treatment in acute and long-term secondary prevention after transient ischaemic attach and ischaemic stroke
av: Rothwell, P, et al.
Publicerad: (2011)

Specificities of ischemic stroke risk factors in Arab-speaking countries
av: Abboud, H, et al.
Publicerad: (2017)

Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials
av: Rothwell, PM, et al.
Publicerad: (2016)

Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): A randomised, open-label, blinded-endpoint trial
av: Wong, K.S.L., et al.
Publicerad: (2010)

Preliminary evidence of a high risk of bleeding on aspirin plus clopidogrel in aspirin-naive patients in the acute phase after TIA or minor ischaemic stroke.
av: Geraghty, O, et al.
Publicerad: (2010)

Asymptomatic recurrent cerebral ischaemic lesions on diffusion-weighted imaging in the subacute and chronic phase after transient ischaemic attack or minor ischaemic stroke.
av: Mazzucco, S, et al.
Publicerad: (2007)

Effects on colon cancer risk in randomised trials of aspirin
av: Rothwell, P
Publicerad: (2011)

CAST: Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke
av: Chen, Z, et al.
Publicerad: (1997)

Indications for early aspirin use in acute ischaemic stroke: A combined analysis of over 40,000 randomised patients
av: Chen, Z, et al.
Publicerad: (1999)

Aspirin in the prevention of cancer Reply
av: Rothwell, P
Publicerad: (2011)

Atherothrombosis and ischaemic stroke.
av: Rothwell, P
Publicerad: (2007)

Atherothrombosis and ischaemic stroke
av: Rothwell, P
Publicerad: (2007)

Antiplatelet treatment after TIA and ischaemic stroke in patients with cerebral microbleeds in two large cohorts
av: Lau, KK, et al.
Publicerad: (2018)

Aspirin, salicylates and cancer
av: Morgan, G, et al.
Publicerad: (2011)

Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials.
av: Vahedi, K, et al.
Publicerad: (2007)

Reliability, reproducibility and validity of dynamic cerebral autoregulation in a large cohort with transient ischaemic attack or minor stroke
av: Lee, Y-K, et al.
Publicerad: (2020)

Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies
av: Wilson, D, et al.
Publicerad: (2019)

Recent advances in management of transient ischaemic attacks and minor ischaemic strokes.
av: Rothwell, P, et al.
Publicerad: (2006)

Non-invasive quantification of cerebral oxygenation in ischaemic stroke using MRI
av: Cherukara, M
Publicerad: (2020)

Alternate-day, low-dose aspirin and cancer risk.
av: Rothwell, P
Publicerad: (2013)

The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke
av: Sandercock, P, et al.
Publicerad: (1997)

A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults
av: Mai, N, et al.
Publicerad: (2018)

Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial
av: Gaziano, J, et al.
Publicerad: (2018)

Low birthweight and ischaemic heart disease.
av: Rothwell, P
Publicerad: (1994)

Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.
av: Flossmann, E, et al.
Publicerad: (2007)

Familiar frequency of ischaemic stroke and transient ischaemic attack in relation to clinical subtype and intermediate phenotypes
av: Rothwell, P, et al.
Publicerad: (2001)

Apolipoproteins predict ischaemic stroke in patients with a previous transient ischaemic attack
av: Bhatia, M, et al.
Publicerad: (2004)

Paramedics should delay giving aspirin to patients with stroke.
av: Ward, M, et al.
Publicerad: (2000)

Potential biomarker for aspirin use in colorectal cancer therapy.
av: Langley, R, et al.
Publicerad: (2013)

Commentary: aspirin and colorectal cancer an epidemiological success story.
av: Flossmann, E, et al.
Publicerad: (2007)